Recruitment to a clinical trial improves glycemic control in patients with diabetes

Diabetes Care

Volumn 30, Issue 12, 2007, Pages 2989-2992

  Gale, Edwin A M ^a,d   Beattie, Scott D ^b   Hu, Jinghui ^b   Koivisto, Veikko ^c   Tan, Meng H ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c Lilly Research Laboratories   (Germany)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN LISPRO; ISOPHANE INSULIN; METFORMIN;

ADULT; AGED; ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; SCREENING TEST;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 37149033475     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0155     Document Type: Article

References (14)

1. Ismail K, Winkley K, Rabe-Hesketh S: Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 363:1589-1597, 2004
2. Devries JH, Snoek FJ, Kostense PJ, Heine RJ: Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial: mechanisms and implications. Diabetes Metab Res Rev 19:357-362, 2003
3. Holleman F, Schmitt H, Rottiers R, Rees A, Symanowski S, Anderson JH: Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro: the Benelux-UK Insulin Lispro Study Group. Diabetes Care 20:1827-1832, 1997
4. Gale EAM: A randomised controlled trial comparing insulin lispro with soluble insulin in patients with type 1 diabetes on intensified insulin therapy. Diabet Med 17:209-214, 2000
5. Bastyr EJ 3rd, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE: Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering A1C: IOEZ Study Group. Diabetes Care 23:1236-1241, 2000
6. Bastyr EJ III, Zagar A, Graf CJ, Fletcher AL: Insulin lispro (LP) versus humulin 70/30 following secondary oral agent failure in primary care (Abstract). Diabetes 49 (Suppl. 1):A97, 2000
7. Holcombe JH, ZagarAJ, Pinaire JA, Prince MJ: Superiority of insulin lispro 75/25 compared with NPH when used in combination with metformin (MET) (Abstract). Diabetes 51 (Suppl. 2):A101, 2002
8. Rohlfing CL, England JD, Wiedmeyer H-M, Tennill A, Little RR, Goldstein DE: Defining the relationship between plasma glucose and A1C. Diabetes Care 25:275-278, 2002
9. Barnett AG, van der Pols JC, Dobson AJ: Regression to the mean: what it is and how to deal with it. Int J Epidemiol 34:215-220, 2005
10. Gillespie R: Manufacturing Knowledge: A History of the Hawthorne Experiments. Cambridge, U.K., Cambridge University Press, 1991
11. Roethlisberger FJ, Dickson WJ: Management and the Worker. Cambridge, Massachusetts, Harvard University Press, 1939
12. Gale EAM: The Hawthorne studies: a fable for our times? Quart J Med 97:439-449, 2004
13. Martin AR, Wolf MA, Thibodeau LA, Dzau V, Braunwald E: A trial of two strategies to modify the test-ordering behavior of medical residents. N Engl J Med 303:1330-1336, 1980
14. Worth R, Home PD, Johnston DG, Anderson J, Ashworth L, Burrin JM, Appleton D, Binder C, Alberti KGMM: Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br Med J 285:1233-1240, 1982